130 related articles for article (PubMed ID: 11257816)
1. [Great discrepancies between European, Dutch and Belgian criteria for the use of statins in the prevention of primary cardiovascular disease in family practice].
Van Diest E; Stoffelen E; Wydooghe L; Van Duppen D; Seuntjens L; Van der Stuyft P
Ned Tijdschr Geneeskd; 2001 Feb; 145(8):361-6. PubMed ID: 11257816
[TBL] [Abstract][Full Text] [Related]
2. Primary prevention of cardiovascular diseases by lipid-lowering treatment in German general practice: results from GPs ignoring guidelines and risk calculators.
Oriol-Zerbe C; Abholz HH
Eur J Gen Pract; 2007; 13(1):27-34. PubMed ID: 17366291
[TBL] [Abstract][Full Text] [Related]
3. Dyslipidemias and the primary prevention of cardiovascular disease: analysis of the FAMUS primary care register.
Xhignesse M; Laplante P; Niyonsenga T; Courteau J; Grant AM
Can J Cardiol; 2000 Jul; 16(7):879-85. PubMed ID: 10934306
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.
Cuspidi C; Meani S; Salerno M; Severgnini B; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
Blood Press; 2004; 13(3):144-51. PubMed ID: 15223722
[TBL] [Abstract][Full Text] [Related]
5. [The PreFord Study. A prospective cohort study to evaluate the risk of a cardiovascular event (overall-collective) as well as a prospective, randomized, controlled, multicentre clinical intervention study (high-risk-collective) on primary prevention of cardiovascular diseases in the Ford Motor Company employees in Germany].
Gysan DB; Latsch J; Bjarnason-Wehrens B; Albus C; Falkowski G; Herold G; Mey E; Heinzler R; Montiel G; Schneider CA; Stützer H; Türk S; Weisbrod M; Predel HG
Z Kardiol; 2004 Feb; 93(2):131-6. PubMed ID: 14963679
[TBL] [Abstract][Full Text] [Related]
6. [Prospective comparison of the flow chart for laboratory investigations for anaemia from the Dutch College of General Practitioners' guideline 'Anaemia' with a self-developed, substantive and logistical alternative flow chart].
Oosterhuis WP; van der Horst M; van Dongen K; Ulenkate HJ; Volmer M; Wulkan RW
Ned Tijdschr Geneeskd; 2007 Oct; 151(42):2326-32. PubMed ID: 18064935
[TBL] [Abstract][Full Text] [Related]
7. [Cost of cardiovascular risk factor prevention in middle-aged French men. The PRIME study].
Marques-Vidal P; Arveiler D; Amouyel P; Ducimetière P; Ferrières J
Rev Epidemiol Sante Publique; 2001 Dec; 49(6):541-9. PubMed ID: 11845103
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular medications in primary care: treatment gaps and targeting by absolute risk.
Rafter N; Connor J; Hall J; Jackson R; Martin I; Parag V; Vander Hoorn S; Rodgers A
N Z Med J; 2005 Oct; 118(1223):U1676. PubMed ID: 16224500
[TBL] [Abstract][Full Text] [Related]
9. [The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports].
Silber S; Richartz BM; Brilmayer M;
Herz; 2006 Dec; 31(9):836-46, 848. PubMed ID: 17180646
[TBL] [Abstract][Full Text] [Related]
10. A hospital-based network for hyperlipidaemia management and cardiovascular disease prevention.
Pujia A;
Nutr Metab Cardiovasc Dis; 2002 Aug; 12(4):198-203. PubMed ID: 12514940
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of patients with acute coronary syndromes in the Netherlands in 2000-2001; a comparison with other European countries and with the guidelines].
Nieuwlaat R; Vermeer F; Scholte op Reimer WJ; Boersma E; van 't Hof AW; Simoons ML
Ned Tijdschr Geneeskd; 2004 Sep; 148(38):1878-82. PubMed ID: 15497784
[TBL] [Abstract][Full Text] [Related]
12. Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001.
Hartz I; Njølstad I; Eggen AE
Eur Heart J; 2005 Dec; 26(24):2673-80. PubMed ID: 16204260
[TBL] [Abstract][Full Text] [Related]
13. Adherence to a guideline on cardiovascular prevention: a comparison between general practitioners and practice nurses.
Voogdt-Pruis HR; Van Ree JW; Gorgels AP; Beusmans GH
Int J Nurs Stud; 2011 Jul; 48(7):798-807. PubMed ID: 21176903
[TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
Kok L; Engelfriet P; Jacobs-van der Bruggen MA; Hoogenveen RT; Boshuizen HC; Verschuren MW
Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):371-6. PubMed ID: 19305351
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between te general practice guidelines for the diagnosis of hypertension and the indication for treatment and practice in the Nijmegen region, the Netherlands, 1983-2001].
Bakx JC; Deunk L; van Gerwen WH; van Aalst M; van den Hoogen HJ; van den Bosch WJ
Ned Tijdschr Geneeskd; 2003 Mar; 147(13):612-5. PubMed ID: 12701396
[TBL] [Abstract][Full Text] [Related]
16. Impact of guidelines on health care use for the management of dyslipidemia in two Canadian provinces, Alberta and Nova Scotia, from 1990 to 2001.
Joffres MR; Kamath TV; Williams GR; Casey J; Svenson LW
Can J Cardiol; 2004 Jun; 20(8):767-72. PubMed ID: 15229757
[TBL] [Abstract][Full Text] [Related]
17. Coronary risk estimates and decisions on lipid-lowering treatment in primary prevention: comparison between general practitioners, internists, and cardiologists.
Vancheri F; Strender LE; Montgomery H; Skånér Y; Backlund LG
Eur J Intern Med; 2009 Oct; 20(6):601-6. PubMed ID: 19782921
[TBL] [Abstract][Full Text] [Related]
18. Development of indicators for assessing the quality of prescribing of lipid-lowering drugs: data from the pharmacotherapeutic quality circles in Hesse, Germany.
Schubert ; Köster ; Ihle P; von Ferber L
Int J Clin Pharmacol Ther; 2001 Nov; 39(11):492-8. PubMed ID: 11727970
[TBL] [Abstract][Full Text] [Related]
19. The use of cardiovascular risk factor information in practice databases: making the best of patient data.
Marshall T
Br J Gen Pract; 2006 Aug; 56(529):600-5. PubMed ID: 16882378
[TBL] [Abstract][Full Text] [Related]
20. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
